Evaluation the efficacy of D-Chiro-Inositol in endometriosis
Phase 2
Recruiting
- Conditions
- Endometriosis is characterized by the presence of endometrial and stromal tissue outside the uterine cavity.Endometriosis
- Registration Number
- IRCT20230111057113N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Age between 20 and 40 years old
Diagnosis of endometriosis
Refusal to use other standard therapies
Systemic estradiol >90 pg/ml during the first 4 days after the end of menstrual cycle.
informed consent to entry
Pelvic pain that has been present for at least three months
Exclusion Criteria
Diagnosis of secreting tumors
previous history of Diabetes Melitus
BMI>30
Taking hormones or inositol within 6 months before starting the study
Using other drugs, especially (OCP and...)
Any disease that interferes with the use of D-chiroinositol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pelvic pain. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: VAS score.
- Secondary Outcome Measures
Name Time Method Pelvic pain. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: VAS score.;Dyspareunia. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: Vas score.;Dysmenorrhea. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: Vas score.;Dyschezia. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: Vas score.